Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
Gabriele Civiletto
1
,
Tatiana Varanita
2
,
Raffaele Cerutti
3
,
Tatiana Gorletta
4
,
Serena Barbaro
4
,
Silvia Marchet
4
,
Costanza Lamperti
4
,
Carlo Viscomi
1
,
Luca Scorrano
5
,
Massimo Zeviani
1
1
MRC-Mitochondrial Biology Unit, Cambridge, UK
|
2
Dulbecco Telethon Institute, Venetian Institute of Molecular Medicine, Padova, Italy
|
3
MRC Mitochondrial Biology Unit, Cambridge, , UK
|
4
Publication type: Journal Article
Publication date: 2015-06-02
scimago Q1
wos Q1
SJR: 11.989
CiteScore: 45.5
Impact factor: 30.9
ISSN: 15504131, 19327420
PubMed ID:
26039449
Molecular Biology
Cell Biology
Physiology
Abstract
Increased levels of the mitochondria-shaping protein Opa1 improve respiratory chain efficiency and protect from tissue damage, suggesting that it could be an attractive target to counteract mitochondrial dysfunction. Here we show that Opa1 overexpression ameliorates two mouse models of defective mitochondrial bioenergetics. The offspring from crosses of a constitutive knockout for the structural complex I component Ndufs4 (Ndufs4(-/-)), and of a muscle-specific conditional knockout for the complex IV assembly factor Cox15 (Cox15(sm/sm)), with Opa1 transgenic (Opa1(tg)) mice showed improved motor skills and respiratory chain activities compared to the naive, non-Opa1-overexpressing, models. While the amelioration was modest in Ndufs4(-/-)::Opa1(tg) mice, correction of cristae ultrastructure and mitochondrial respiration, improvement of motor performance and prolongation of lifespan were remarkable in Cox15(sm/sm)::Opa1(tg) mice. Mechanistically, respiratory chain supercomplexes were increased in Cox15(sm/sm)::Opa1(tg) mice, and residual monomeric complex IV was stabilized. In conclusion, cristae shape amelioration by controlled Opa1 overexpression improves two mouse models of mitochondrial disease.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Cells
6 publications, 2.91%
|
|
|
International Journal of Molecular Sciences
6 publications, 2.91%
|
|
|
Nature Communications
6 publications, 2.91%
|
|
|
Cell Death and Disease
5 publications, 2.43%
|
|
|
Frontiers in Cell and Developmental Biology
5 publications, 2.43%
|
|
|
Cell Metabolism
5 publications, 2.43%
|
|
|
Biochimica et Biophysica Acta - Bioenergetics
5 publications, 2.43%
|
|
|
Mitochondrion
5 publications, 2.43%
|
|
|
Antioxidants
4 publications, 1.94%
|
|
|
Cell Reports
4 publications, 1.94%
|
|
|
Trends in Endocrinology and Metabolism
3 publications, 1.46%
|
|
|
Journal of Cell Science
3 publications, 1.46%
|
|
|
Antioxidants and Redox Signaling
3 publications, 1.46%
|
|
|
Scientific Reports
3 publications, 1.46%
|
|
|
Free Radical Biology and Medicine
3 publications, 1.46%
|
|
|
Biochemical and Biophysical Research Communications
3 publications, 1.46%
|
|
|
Pharmacological Research
3 publications, 1.46%
|
|
|
EMBO Molecular Medicine
3 publications, 1.46%
|
|
|
Science Translational Medicine
3 publications, 1.46%
|
|
|
Journal of Applied Physiology
3 publications, 1.46%
|
|
|
Biochemical Society Transactions
2 publications, 0.97%
|
|
|
Journal of Molecular Medicine
2 publications, 0.97%
|
|
|
Molecular Cell
2 publications, 0.97%
|
|
|
PLoS ONE
2 publications, 0.97%
|
|
|
Redox Biology
2 publications, 0.97%
|
|
|
Experimental Neurology
2 publications, 0.97%
|
|
|
Journal of Biological Chemistry
2 publications, 0.97%
|
|
|
Trends in Molecular Medicine
2 publications, 0.97%
|
|
|
Neurobiology of Disease
2 publications, 0.97%
|
|
|
1
2
3
4
5
6
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
67 publications, 32.52%
|
|
|
Springer Nature
36 publications, 17.48%
|
|
|
MDPI
19 publications, 9.22%
|
|
|
Wiley
15 publications, 7.28%
|
|
|
Frontiers Media S.A.
14 publications, 6.8%
|
|
|
American Association for the Advancement of Science (AAAS)
6 publications, 2.91%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 2.91%
|
|
|
European Molecular Biology Organization
4 publications, 1.94%
|
|
|
American Physiological Society
4 publications, 1.94%
|
|
|
The Company of Biologists
3 publications, 1.46%
|
|
|
Mary Ann Liebert
3 publications, 1.46%
|
|
|
Portland Press
3 publications, 1.46%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 1.46%
|
|
|
Public Library of Science (PLoS)
3 publications, 1.46%
|
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 0.97%
|
|
|
Oxford University Press
2 publications, 0.97%
|
|
|
Annual Reviews
2 publications, 0.97%
|
|
|
American Society for Clinical Investigation
2 publications, 0.97%
|
|
|
Canadian Science Publishing
1 publication, 0.49%
|
|
|
Impact Journals
1 publication, 0.49%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.49%
|
|
|
Taylor & Francis
1 publication, 0.49%
|
|
|
Walter de Gruyter
1 publication, 0.49%
|
|
|
Rockefeller University Press
1 publication, 0.49%
|
|
|
American Chemical Society (ACS)
1 publication, 0.49%
|
|
|
AME Publishing Company
1 publication, 0.49%
|
|
|
Society for Neuroscience
1 publication, 0.49%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.49%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
206
Total citations:
206
Citations from 2024:
24
(11.65%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Civiletto G. et al. Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models // Cell Metabolism. 2015. Vol. 21. No. 6. pp. 845-854.
GOST all authors (up to 50)
Copy
Civiletto G., Varanita T., Cerutti R., Gorletta T., Barbaro S., Marchet S., Lamperti C., Viscomi C., Scorrano L., Zeviani M. Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models // Cell Metabolism. 2015. Vol. 21. No. 6. pp. 845-854.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.cmet.2015.04.016
UR - https://doi.org/10.1016/j.cmet.2015.04.016
TI - Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
T2 - Cell Metabolism
AU - Civiletto, Gabriele
AU - Varanita, Tatiana
AU - Cerutti, Raffaele
AU - Gorletta, Tatiana
AU - Barbaro, Serena
AU - Marchet, Silvia
AU - Lamperti, Costanza
AU - Viscomi, Carlo
AU - Scorrano, Luca
AU - Zeviani, Massimo
PY - 2015
DA - 2015/06/02
PB - Elsevier
SP - 845-854
IS - 6
VL - 21
PMID - 26039449
SN - 1550-4131
SN - 1932-7420
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2015_Civiletto,
author = {Gabriele Civiletto and Tatiana Varanita and Raffaele Cerutti and Tatiana Gorletta and Serena Barbaro and Silvia Marchet and Costanza Lamperti and Carlo Viscomi and Luca Scorrano and Massimo Zeviani},
title = {Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models},
journal = {Cell Metabolism},
year = {2015},
volume = {21},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016/j.cmet.2015.04.016},
number = {6},
pages = {845--854},
doi = {10.1016/j.cmet.2015.04.016}
}
Cite this
MLA
Copy
Civiletto, Gabriele, et al. “Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models.” Cell Metabolism, vol. 21, no. 6, Jun. 2015, pp. 845-854. https://doi.org/10.1016/j.cmet.2015.04.016.